In a report released today, Shane Storey from Wilsons maintained a Buy rating on Telix Pharmaceuticals Ltd. (TLPPF – Research Report), with a ...
10h
Stockhead on MSNHealth Check: Fantastico! Telix wins Brazilian assent for prostate cancer imaging agentBrazil's health regulators have approved Telix Pharmaceuticals' nuclear imaging agent for prostate cancer, Illucix. ... Read ...
4d
Pharmaceutical Technology on MSNTelix’s new lead-212 generator could dispel medical isotope scalability hurdlesLead-212 is a promising radioactive isotope for use in targeted alpha therapy, an alternative modality to beta-particle-based ...
Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has developed and validated ...
Melbourne-based biotech Telix Pharmaceuticals has announced that its prostate cancer diagnostic agent Illuccix has been ...
MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the Brazilian Health ...
The high-flying S&P/ASX 200 Index (ASX: XJO) share made a major acquisition announcement. Here’s what you need to know.
9h
Vietnam Investment Review on MSNIlluccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin AmericaTelix Pharmaceuticals Limited today announces that the Brazilian Health Regulatory Agency has approved Illuccix® the ...
MELBOURNE, Australia and INDIANAPOLIS, March 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has developed and validated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results